Angelo Corti Selected Research

Angelo Corti Research Topics

Disease

78	Neoplasms (Cancer) 01/2024 - 02/2002
12	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 02/2002
10	Neuroblastoma 01/2019 - 11/2003
9	Inflammation (Inflammations) 10/2022 - 01/2009
8	Melanoma (Melanoma, Malignant) 01/2023 - 05/2003
7	Lymphoma (Lymphomas) 07/2022 - 02/2002
7	Adenocarcinoma 01/2020 - 02/2002
5	Heart Failure 11/2019 - 03/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 07/2008
4	Critical Illness (Critically Ill) 10/2022 - 08/2012
4	Hypertension (High Blood Pressure) 11/2019 - 03/2010
4	Disease Progression 01/2019 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 08/2023 - 01/2022
3	COVID-19 01/2023 - 10/2021
3	Hypoxia (Hypoxemia) 10/2021 - 11/2011
3	Fibrosarcoma 05/2021 - 05/2016
3	Rheumatoid Arthritis 11/2019 - 06/2006
3	Insulin Resistance 11/2019 - 01/2017
3	Shock 09/2019 - 08/2012
3	Erdheim-Chester Disease 07/2016 - 10/2012
2	Infections 10/2022 - 09/2019
2	Brain Neoplasms (Brain Tumor) 07/2022 - 05/2021
2	Systolic Heart Failure 02/2022 - 01/2013
2	Atherosclerosis 11/2019 - 06/2017
2	Obesity 11/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2016 - 07/2008
2	Multiple Myeloma 01/2016 - 01/2015
2	Vascular Tissue Neoplasms 12/2013 - 12/2013
2	Necrosis 01/2010 - 07/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2010 - 08/2007
1	Leukemia 01/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Multiple Organ Failure (MODS) 10/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022

Drug/Important Bio-Agent (IBA)

48	Peptides (Polypeptides)IBA 01/2023 - 02/2002
41	Chromogranin AIBA 01/2023 - 02/2002
30	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 02/2002
23	LigandsIBA 01/2024 - 01/2004
21	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
19	CytokinesIBA 07/2022 - 08/2002
15	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021 - 08/2002
14	vasostatin IIBA 02/2022 - 03/2006
13	IntegrinsIBA 08/2023 - 01/2004
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2002
11	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2024 - 11/2003
11	Liposomes (Liposome)IBA 01/2019 - 11/2003
9	NGR peptideIBA 07/2022 - 12/2002
8	AntibodiesIBA 01/2019 - 02/2002
7	GoldIBA 08/2023 - 03/2013
6	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2012
5	human CNGRC fusion protein tumor necrosis factor-alphaIBA 11/2020 - 01/2010
5	chromogranin A (344-364)IBA 11/2019 - 10/2012
5	AntigensIBA 01/2017 - 01/2004
4	EnzymesIBA 01/2024 - 08/2007
4	Cyclic PeptidesIBA 08/2023 - 12/2002
4	Glycine (Aminoacetic Acid)FDA LinkGeneric 09/2017 - 09/2008
4	Isoaspartic Acid (Isoaspartate)IBA 09/2017 - 09/2008
4	Protein Isoforms (Isoforms)IBA 01/2010 - 02/2002
3	AvidinIBA 01/2024 - 05/2003
3	Biotin (Vitamin H)FDA Link 01/2024 - 05/2003
3	Neuropilin-1IBA 11/2022 - 11/2018
3	ChromograninsIBA 11/2022 - 02/2011
3	AlbuminsIBA 10/2022 - 03/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2015
3	Monoclonal AntibodiesIBA 01/2018 - 01/2011
3	liposomal doxorubicin (Doxil)FDA Link 09/2017 - 11/2003
3	Melphalan (Alkeran)FDA LinkGeneric 09/2011 - 01/2004
3	Arginine (L-Arginine)FDA Link 03/2010 - 09/2008
3	Complementary DNA (cDNA)IBA 10/2004 - 02/2002
2	Proton Pump InhibitorsIBA 01/2023 - 01/2016
2	IronIBA 10/2021 - 11/2015
2	Interleukin-12 (IL 12)IBA 05/2021 - 11/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 01/2013
2	Coloring Agents (Dyes)IBA 11/2018 - 01/2011
2	LipidsIBA 01/2018 - 01/2009
2	Hormones (Hormone)IBA 07/2016 - 12/2010
2	Fibrinolysin FDA Link 01/2016 - 11/2002
2	Infliximab (Remicade)FDA Link 01/2014 - 10/2012
2	ChemokinesIBA 09/2012 - 03/2012
2	vasectrin I (VS I)IBA 09/2012 - 08/2012
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2007 - 08/2002
1	polypeptide CIBA 01/2024
1	Contrast MediaIBA 08/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	IRDye 800CWIBA 01/2023
1	cysteinylglycine (Cys-Gly)IBA 07/2022
1	C-Reactive ProteinIBA 01/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022
1	SaporinsIBA 01/2022
1	lactate dehydrogenase C4IBA 10/2021
1	AlarminsIBA 10/2021
1	CreatinineIBA 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021

Therapy/Procedure

29	Therapeutics 01/2024 - 02/2002
13	Drug Therapy (Chemotherapy) 10/2020 - 08/2002
4	Immunotherapy 07/2022 - 03/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 01/2017
1	Intravesical Administration 08/2023
1	Art Therapy 01/2022